Elan Corporation

Pharmaceutical company

About Us

Products

Elan Drug Technologies

Research & Development

News

Investor Relations

Careers

Governance

• Shareholder Info
• Financials
• Events & Webcasts
• Company Overview
• Corporate Governance
• Senior Management
• Information Request
• Contacts

Latest Share Price Last Trade Change Volume Date & Time Stock Chart NYSE 33.64 +1.30 5,085,985 Jul 25 2008 4:03PM Quotes are refreshed every 20 minutes

Events 3 May 2007 American Academy of Neurology 59th Annual Meeting 15 March 2007 Elan-Wyeth Symposium: Immunotherapy for Treatment of AD &  PD Webcasts 29th July 2008 Elan Corporation, plc / Wyeth Conference Call 24th July 2008 Q2 2008 Elan Corporation, Plc Earnings Conference Call 11th June 2008 Elan Corporation, plc at Goldman Sachs Healthcare Conference Latest Press Releases 24th July 2008 Elan Reports Second Quarter 2008 Financial Results 22nd July 2008 Elan and Wyeth Announce Webcast To Discuss Bapineuzumab Phase 2 Clinical Trial Results 22nd July 2008 Biogen Idec and Elan Celebrate Second Anniversary of TYSABRI® for the Treatment of Multiple Sclerosis

Please allow sufficient time to download

Copyright © 2001- 2004 Elan Corporation, plc, Dublin, Ireland. All rights reserved. | Privacy Policy | Terms of use